Compound Summary
Compound Name: | 			3',4'-Dichlorobenzamil | 
Compound CID: | 			114771 | 
Synonyms: | 			"3,4-Dichlorobenzamil dichlorobenzamil 3,4-dichlorobenzamil 1166-01-4 GNF-Pf-1778 More... | 
Iupac Name: | 			3,5-diamino-6-chloro-N-[N'-[(3,4-dichlorophenyl)methyl]carbamimidoyl]pyrazine-2-carboxamide | 
InChI: | 					InChI=1S/C13H12Cl3N7O/c14-6-2-1-5(3-7(6)15)4-20-13(19)23-12(24)8-10(17)22-11(18)9(16)21-8/h1-3H,4H2,(H4,17,18,22)(H3,19,20,23,24) | 
InChIKey: | 				OSHKWEFWXCCNJR-UHFFFAOYSA-N | 
Canonical Smiles: | 		C1=CC(=C(C=C1CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N)Cl)Cl | 
Isomeric Smiles: | 			C1=CC(=C(C=C1CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N)Cl)Cl | 
Molecular Weight: | 		388.6 | 
Molecular Formula: | 			C13H12Cl3N7O | 
Molecular Weight: | 		388.6 | 
Molecular Formula: | 			C13H12Cl3N7O | 
Hydrogen Bond Donor Count: | 			4 | 
Hydrogen Bond Acceptor Count: | 			6 | 
Rotatable Bond Count: | 			4 | 
Heavy Atom Count: | 					24 | 
Complexity: | 				481 | 
| 3',4'-Dichlorobenzamil | 3',4'-Dichlorobenzamil | 
|---|---|
"3,4-Dichlorobenzamil | 			
dichlorobenzamil | 
3,4-dichlorobenzamil | 			
1166-01-4 | 
GNF-Pf-1778 | 			
3,5-diamino-6-chloro-N-N-(3,4-dichlorophenyl)methylcarbamimidoylpyrazine-2-carboxamide" | 
3,4-Dichlorobenzamil hydrochloride" | 			
3,5-diamino-6-chloro-N-N-(3,4-dichlorophenyl)methylcarbamimidoylpyrazine-2-carboxamide;hydrochloride | 
L-594,881 | 			
Lopac-D-8190 | 
Lopac0_000413 | 			
CHEMBL587714 | 
GTPL4597 | 			
SCHEMBL10844588 | 
DTXSID30922105 | 			
CHEBI:125553 | 
ZINC9226184 | 			
MFCD03839362 | 
CCG-204505 | 			
NCGC00015373-01 | 
NCGC00015373-02 | 			
NCGC00162146-01 | 
BRD-K41049123-001-01-3 | 			
Q27073358 | 
3,5-Diamino-6-chloro-N-(((3,4-dichlorophenyl)amino)iminomethyl)pyrazinecarboxamide | 			
3,5-Diamino-6-chloro-N-(N-(3,4-dichlorobenzyl)carbamimidoyl)pyrazine-2-carboxamide | 
Pyrazinecarboxamide, 3,5-diamino-6-chloro-N-(((3,4-dichlorophenyl)amino)iminomethyl)- | 			
2-Pyrazinecarboxamide,3,5-diamino-6-chloro-N-(3,4-dichlorophenyl)methylaminoiminomethyl- | 
3,5-diamino-6-chloro-N-(E)-N-(3,4-dichlorophenyl)methylcarbamimidoylpyrazine-2-carboxamide | 			
3,5-Diamino-6-chloro-N-{N-(3,4-dichlorophenyl)methylcarbamimidoyl}pyrazine-2-carboximidic acid | 
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -25.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | -25.000000000000000 | 1 | 1 |